Cover Image

Dalbavancin in the treatment of skin and soft tissues infection

Saved in:

Bibliographic Details
Main Authors:	Ana Candela Fajardo (Author), Elena Urbieta Sanz (Author), Cristóbal Gallego Muñoz (Author)
Format:	Book
Published:	Elsevier, 2017-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review
by: Jason W Bennett, et al.
Published: (2008)

Real-World Use of Dalbavancin for Treatment of Soft Tissue and Bone Infection in Children: Safe, Effective and Hospital-Time Sparing
by: Désirée Caselli, et al.
Published: (2024)

Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
by: Leuthner KD, et al.
Published: (2016)

Safety and Efficacy of Dalbavancin in Real Life: Retrospective Analysis of a Large Monocentric Case Series of Patients Treated for Skin/Soft Tissue and Other Difficult-to-Treat Infections
by: Giustino Parruti, et al.
Published: (2024)

In Vitro Activities of Ceftobiprole, Dalbavancin, Tedizolid and Comparators against Clinical Isolates of Methicillin-Resistant <i>Staphylococcus aureus</i> Associated with Skin and Soft Tissue Infections
by: Sofia Maraki, et al.
Published: (2023)

New developments in the treatment of acute bacterial skin and skin structure infections: considerations for the effective use of dalbavancin
by: Juul JJ, et al.
Published: (2016)

Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections
by: Giacomo Stroffolini, et al.
Published: (2022)

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
by: Pedro Luis Gonzalez, et al.
Published: (2018)

Purulent Skin and Soft Tissue Infection
by: Steven Alexander Kahn MD, et al.
Published: (2010)

Dalbavancin for Acute Bacterial Skin and Skin Structure Infections in Pediatrics: Insights from Continuation Therapy Experience
by: Sara Maria Scarano, et al.
Published: (2024)

Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review
by: Luis Buzón-Martín, et al.
Published: (2021)

Topical Antiseptic Formulations for Skin and Soft Tissue Infections
by: Thi Phuong Nga Hoang, et al.
Published: (2021)

Impact of Antibiotic Stewardship on Treatment of Hospitalized Children with Skin and Soft-Tissue Infections
by: Giulia Brigadoi, et al.
Published: (2024)

New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics
by: Nicola Principi, et al.
Published: (2020)

Use of Dalbavancin in Skin, Bone and Joint Infections: A Real-Life Experience in an Italian Center
by: Lucia Brescini, et al.
Published: (2021)

A Narrative Review on the Role of Dalbavancin in the Treatment of Bone and Joint Infections
by: Dimitra Dimopoulou, et al.
Published: (2023)

Comparative pharmacoeconomic analysis of ceffaroline fosamil in the treatment of complicated skin and soft tissues infections
by: S. K. Zyryanov, et al.
Published: (2018)

Dalbavancin in Bone and Joint Infections: A Systematic Review
by: Sofia Lovatti, et al.
Published: (2023)

Efficacy and Safety of Iclaprim for the Treatment of Skin Structures and Soft Tissue Infections: A Methodological Framework
by: Lian Wang, et al.
Published: (2022)

Comparative Evaluation of Existing and Rationally Designed Novel Antimicrobial Peptides for Treatment of Skin and Soft Tissue Infections
by: Anna Ramata-Stunda, et al.
Published: (2023)

Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina
by: Mary C. Figgatt, et al.
Published: (2021)

Clinical Impact of <i>Staphylococcus aureus</i> Skin and Soft Tissue Infections
by: Matthew S. Linz, et al.
Published: (2023)

Expression of Staphylococcal Virulence Genes In Situ in Human Skin and Soft Tissue Infections
by: Michael S. Pulia, et al.
Published: (2022)

Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia
by: Mpenge MA, et al.
Published: (2015)

Acute bacterial skin and soft tissue infections: new drugs in ID armamentarium
by: Raghavendra Tirupathi, et al.
Published: (2019)

Successful use of dalbavancin in the treatment of gram positive blood stream infections: a case series
by: Connor Evins, et al.
Published: (2022)

Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety
by: Andrés Ruiz-Sancho, et al.
Published: (2023)

Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
by: Leama Ajaka, et al.
Published: (2020)

Determination of the Elution Capacity of Dalbavancin in Bone Cements: New Alternative for the Treatment of Biofilm-Related Peri-Prosthetic Joint Infections Based on an <i>In Vitro</i> Study
by: Mar Sánchez-Somolinos, et al.
Published: (2022)

Principales novedades en relación al manejo y tratamiento farmacológico en pacientes con insuficiencia cardiaca: lo que el farmacéutico debe conocer
by: Cristóbal Gallego Muñoz, et al.
Published: (2017)

Principales novedades en relación al manejo y tratamiento farmacológico en pacientes con insuficiencia cardiaca: lo que el farmacéutico debe conocer
by: Cristóbal Gallego Muñoz, et al.
Published: (2017)

Necrotizing Soft Tissue Infection
by: Sahil Aggarwal, BS, et al.
Published: (2018)

Skin and Soft Tissue Infections Caused by Mycobacterium chelonae: More Common Than Expected?
by: Ugur Uslu, et al.
Published: (2019)

Nocardia takedensis: a newly recognized pathogen responsible for skin and soft tissue infections
by: Romain Lotte, et al.
Published: (2020)

The Etiology, Antibiotic Therapy and Outcomes of Bacteremic Skin and Soft-Tissue Infections in Onco-Hematological Patients
by: Valeria Castelli, et al.
Published: (2023)

In Vitro Efficacy of Dalbavancin as a Long-Acting Anti-Biofilm Agent Loaded in Bone Cement
by: Mar Sánchez-Somolinos, et al.
Published: (2023)

Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections and minocyclin treatment experience in the dermatological setting of eastern Taiwan
by: Tzu-Chun Lin, et al.
Published: (2011)

Clinical Characteristics and Treatment Outcomes of Pediatric Bacterial Skin and Soft Tissue Infections in Central Vietnam: A Prospective Study
by: Chau Duc Nguyen-Huu MD, PhD, et al.
Published: (2024)

The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa
by: Elisa Molinelli, et al.
Published: (2022)

Evaluating the Use of Dalbavancin for Off-Label Indications
by: Katherine Taylor, et al.
Published: (2022)